Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received ...

Maternal hidradenitis suppurativa was linked to an increased risk for pregnancy complications and long-term adverse outcomes in mothers and children.

In a response to a survey, caregivers of people with spinal muscular atrophy identified the risk of severe adverse events and ...

In this cohort study of hospital admissions among Medicare patients during the COVID-19 pandemic, greater hospital COVID-19 burden was associated with an increased risk of in-hospital adverse effects ...

Distinct immune "signatures" in patients who develop adverse events while receiving immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...

Introduction: Systematic collection of diverse adverse events during herbal medicine administration is crucial. The Korea Adverse Event Reporting System (KAERS) compiles spontaneously reported adverse ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Dr Graff discusses the differences and similarities in managing adverse events associated with bispecific antibodies in ...

Our objectives were to assess the risk and predictors of major adverse events associated with noncardiac surgery within 1 year after CABG. Methods: In a retrospective review of medical records at ...